Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial

[1]  M. Cenzato,et al.  Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study. , 2010, Archives of neurology.

[2]  C. Finch,et al.  A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures , 2010, Journal of Neuro-Oncology.

[3]  M. Donat,et al.  Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery , 2010, Journal of Neuro-Oncology.

[4]  D. Lachance,et al.  Seizures in patients with glioma treated with phenytoin and levetiracetam. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Taphoorn,et al.  Efficacy of anti-epileptic drugs in patients with gliomas and seizures , 2009, Journal of Neurology.

[6]  P. Muti,et al.  Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study , 2009, Neurological Sciences.

[7]  Phiroz E. Tarapore,et al.  Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study , 2009, Journal of Neuro-Oncology.

[8]  E. Bromfield,et al.  Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery , 2008, Neurology.

[9]  A. Beydoun,et al.  Valproate‐induced thrombocytopenia: a prospective monotherapy study , 2008, Epilepsia.

[10]  C. Vecht,et al.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management , 2007, The Lancet Neurology.

[11]  C. Elger,et al.  Levetiracetam Intravenous Infusion as an Alternative to Oral Dosing in Patients with Partial‐Onset Seizures , 2007, Epilepsia.

[12]  C. Vecht,et al.  Optimizing therapy of seizures in patients with brain tumors , 2006, Neurology.

[13]  H. Meencke,et al.  Assessment of a dose–response relationship of levetiracetam , 2006, European journal of neurology.

[14]  S. Ramael,et al.  Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic Study , 2006, Epilepsia.

[15]  M. Sperling,et al.  Seizures and brain tumors. , 2006, Seminars in oncology.

[16]  S. Ramael,et al.  Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. , 2006, Clinical therapeutics.

[17]  E. Perucca.  British Journal of Clinical Pharmacology Clinically Relevant Drug Interactions with Antiepileptic Drugs , 2022 .

[18]  M. Maschio,et al.  Issues related to the pharmacological management of patients with brain tumours and epilepsy. , 2006, Functional neurology.

[19]  J. Bier,et al.  Computerized bedside assessment of intentional neglect: A pilot study , 2005 .

[20]  M. Weller,et al.  Pharmacotherapy of Epileptic Seizures in Glioma Patients: Who, When, Why and How Long? , 2005, Oncology Research and Treatment.

[21]  C. Vecht,et al.  Optimal seizure management in brain tumor patients , 2005, Current neurology and neuroscience reports.

[22]  S. Howng,et al.  Factors influencing seizures in adult patients with supratentorial astrocytic tumors , 2004, Acta Neurochirurgica.

[23]  C. Vecht,et al.  Treating seizures in patients with brain tumors: Drug interactions between antiepileptic and chemotherapeutic agents. , 2003, Seminars in oncology.

[24]  S. Rüegg,et al.  Brain Tumor and Seizures: Pathophysiology and Its Implications for Treatment Revisited , 2003, Epilepsia.

[25]  C. Vecht,et al.  Interactions between antiepileptic and chemotherapeutic drugs , 2003, The Lancet Neurology.

[26]  H. Lahrmann,et al.  [The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna]. , 2002, Wiener klinische Wochenschrift.

[27]  L. Recht,et al.  Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors , 2000, Neurology.

[28]  I. R. Whittle,et al.  The Pathogenesis of Tumour Associated Epilepsy , 2000, Acta Neurochirurgica.

[29]  L. Raus,et al.  Epilepsy and gliomas: incidence and treatment in 119 patients. , 1998, Journal of experimental & clinical cancer research : CR.

[30]  R. Maciunas,et al.  The course of seizure disorders in patients with malignant gliomas. , 1995, Archives of neurology.